Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using sustained delivery of therapeutic proteins from a patient’s own cells. The company is developing a technology platform called Immune System Programming (ISP™), which modifies a patient’s B cells and instructs them to produce gene-encoded medicines. The B cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients and provide therapeutic benefit for many years. The company is based in Seattle, WA.
View Top Employees from ImmusoftWebsite | http://immusoft.com |
Revenue | $2 million |
Funding | $25.3 million |
Employees | 20 (15 on RocketReach) |
Founded | 2009 |
Address | 454 N 34th St, Seattle, Washington 98103, US |
Phone | (206) 397-0028 |
Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Program a patient's cells to produce antibodies, and enzymes, Business Services, Science and Engineering, Enables an entire new set of treatments options for patients, Therapeutics, Scope of applicability extensive; for use in many diseases, Health Care, Patient convenience; eliminates frequent needle injections |
Web Rank | 17 Million |
Keywords | Immusoft Careers, Plasma Cell Survival Culture, Immusoft |
Competitors | American Gene Technologies® International Inc., GQ Bio Therapeutics, SENSORION, SanBio, Semma Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 325414 Companies |
Looking for a particular Immusoft employee's phone or email?
The Immusoft annual revenue was $2 million in 2023.
Jacob Wesley is the Vice President, Medical Sciences of Immusoft.
15 people are employed at Immusoft.
Immusoft is based in Seattle, Washington.
The NAICS codes for Immusoft are [32, 3254, 325, 32541, 325414].
The SIC codes for Immusoft are [87, 873].